A Clinical Trial to Evaluate the Efficacy and Safety of CKD-391 and CKD-331 in Patients With Primary Hypercholesterolemia
Status:
Recruiting
Trial end date:
2023-06-01
Target enrollment:
Participant gender:
Summary
This is a randomized, double-blind, multi-center, therapeutic confirmatory, phase 3 trial to
evaluate the efficacy and safety of CKD-391 and CKD-331 in patients with primary
hypercholesterolemia